These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9657483)

  • 1. Testing the efficacy of lipid-lowering therapy versus revascularization: the time has come, or is it past due?
    Enas EA
    Circulation; 1998 Jun; 97(25):2584-6. PubMed ID: 9657483
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
    Deedwania PC; Carbajal EV
    Am J Med; 2011 Aug; 124(8):681-8. PubMed ID: 21787900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary revascularization: an opportunity for lipid screening and treatment.
    Polk DM; Keilson LM; Malenka DJ; McGowan MP; Ades PA;
    J Interv Cardiol; 2001 Feb; 14(1):109-12. PubMed ID: 12053318
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid lowering versus revascularization: an idea whose time (for testing) has come.
    Forrester JS; Shah PK
    Circulation; 1997 Aug; 96(4):1360-2. PubMed ID: 9286970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial revascularization: a 20-year lesson.
    Shanahan MX; Virdi IS
    Med J Aust; 1989 Jun; 150(12):671-3. PubMed ID: 2567487
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of lipid-lowering medication in patients with acute myocardial infarction (Worcester Heart Attack Study).
    Goldberg RJ; Ockene IS; Yarzebski J; Savageau J; Gore JM
    Am J Cardiol; 1997 Apr; 79(8):1095-7. PubMed ID: 9114770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary prevention of coronary disease with lipid-lowering drugs.
    Lancet; 1989 Mar; 1(8636):473-4. PubMed ID: 2563844
    [No Abstract]   [Full Text] [Related]  

  • 8. How do prescribing doctors anticipate the effect of statins?
    Lytsy P; Burell G; Westerling R
    J Eval Clin Pract; 2011 Jun; 17(3):420-8. PubMed ID: 20545813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipid-lowering therapy in patients with coronary disease: proportion of patients requiring treatment according to recommendations of the Swiss Society of Cardiology].
    Muntwyler J; Amann FW; Gutzwiller F; Follath F
    Schweiz Med Wochenschr; 1999 Dec; 129(50):1959-63. PubMed ID: 10637948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-lowering therapy after myocardial infarction: the Bavarian Cholesterol Screening Project.
    Richter WO; Schwandt P
    JAMA; 1998 Aug; 280(7):603-4. PubMed ID: 9718050
    [No Abstract]   [Full Text] [Related]  

  • 11. Time trend analysis and variations in prescribing lipid lowering drugs in general practice.
    Baxter C; Jones R; Corr L
    BMJ; 1998 Oct; 317(7166):1134-5. PubMed ID: 9784452
    [No Abstract]   [Full Text] [Related]  

  • 12. Benefits of lipid-lowering agents in stroke and coronary heart disease: pharmacoeconomics.
    Rockson SG
    Curr Atheroscler Rep; 2000 Mar; 2(2):144-50. PubMed ID: 11122738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing prescription of drugs for secondary prevention of myocardial infarction. Lipid lowering drugs should be considered too.
    Taylor A; Reckless JP
    BMJ; 1996 Jan; 312(7025):252. PubMed ID: 8563613
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of statins on six-month survival and clinical restenosis frequency after coronary stent deployment.
    Bunch TJ; Muhlestein JB; Anderson JL; Horne BD; Bair TL; Jackson JD; Li Q; Lappé DL
    Am J Cardiol; 2002 Aug; 90(3):299-302. PubMed ID: 12127616
    [No Abstract]   [Full Text] [Related]  

  • 15. Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial.
    Tikkanen MJ; Szarek M; Fayyad R; Holme I; Cater NB; Faergeman O; Kastelein JJ; Olsson AG; Larsen ML; Lindahl C; Pedersen TR;
    J Am Coll Cardiol; 2009 Dec; 54(25):2353-7. PubMed ID: 20082922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3.
    Fonarow GC; French WJ; Parsons LS; Sun H; Malmgren JA
    Circulation; 2001 Jan; 103(1):38-44. PubMed ID: 11136683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Lipid-lowering drugs after myocardial infarction.
    Lancet; 1975 Mar; 1(7905):501-2. PubMed ID: 46964
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical thinking on the intensive lipid-lowering therapy].
    Zhao SP; Chen YQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Sep; 39(9):791-2. PubMed ID: 22321223
    [No Abstract]   [Full Text] [Related]  

  • 19. Impending infarction should be prevented by myocardial revascularization (surgical viewpoint).
    Favaloro RG
    Cardiovasc Clin; 1977; 8(1):53-7. PubMed ID: 849599
    [No Abstract]   [Full Text] [Related]  

  • 20. [Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)].
    Szucs TD; Schwenkglenks M; Rutishauser W
    Med Klin (Munich); 2000 Jan; 95(1):1-13. PubMed ID: 10668338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.